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Background: Prompt and appropriate treatment of malaria with effective medicines remains necessary if malaria
control goals are to be achieved. The theoretical concepts from self-care and the health belief model were used to
examine the motivations for malaria self-care among the adult population.
Methods: A qualitative study was conducted through eight focus group discussions with adult community
members to explore their general opinions, views and perceptions of malaria and of its treatments. These groups
were followed by 15 in-depth interviews of participants with a recent malaria experience to allow for an in-depth
exploration of their self-care practices. The analysis followed principles of grounded theory and was conducted
using Nvivo 9 qualitative data management software.
Results: The self-treatment of malaria at home was found to be a common practice among the study participants.
The majority of the participants practiced self-medication with a painkiller as an initial response. The persistence
and the worsening of the disease symptoms prompted participants to consider other self-care options. Perceptions
that many malaria symptoms are suggestive of other conditions motivated participants to self-refer for malaria test.
The accessibility of private laboratory facilities and drug shops motivated their use for malaria tests and for obtaining
anti-malarial medicines, respectively. Self-treatment with anti-malarial monotherapy was common, motivated by their
perceived effectiveness and availability. The perceived barriers to using the recommended combination treatment,
artemether-lumefantrine, were related to the possible side-effects and to uncertainty about their effectiveness, and
these doubts motivated some participants to consider self-medication with local herbs. Several factors were mentioned
as motivating people for self-care practices. These included poor patient provider relationship, unavailability of medicine
and the costs associated with accessing treatments from the health facilities.
Conclusions: Malaria self-care and self-treatment with anti-malarial monotherapy are common among adults, and
are motivated by both individual characteristics and the limitations of the existing health care facilities. There is a
need for public health interventions to take into account community perceptions and cultural schemas on malaria
self-care practices.
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Globally, malaria remains a menace. An estimated 219
million cases are reported annually worldwide leading to
660,000 deaths, with sub-Saharan Africa (SSA) account-
ing for 90 percent of the cases [1]. Malaria is an import-
ant cause of death in SSA [1] where 75 percent of 650
million people reside in malaria transmission areas. In
Tcbuanzania 10–12 million clinical malarial cases are
reported annually by public health facilities, with the
disease contributing to more than 40 percent of visits to
health facilities [2]. A recent disease-specific mortality
estimate estimates the cumulative probability of dying
from malaria in Tanzania at 81.1 per 1,000 population
[3]. Under-five children and pregnant women are the
most susceptible to malaria transmission and its subse-
quent effects. Although the overall malaria burden is
generally decreasing throughout Africa [4-9], a shift in
the burden to adults is reported [10]. Thus, in this paper
the focus is on adults and their motives for malaria self-
care practices.
As malaria is preventable and curable [1,5] large-scale
anti-malaria interventions have been initiated by the Roll
Back Malaria Partnership (RBM), the Global Fund to
Fight AIDS, Tuberculosis and Malaria and the President’s
Malaria Initiative (PMI). Currently, four main malaria
control interventions are being pursued: improved malaria
case management, intermittent malaria treatment in
pregnancy, malaria epidemic prevention and control,
and integrated malaria vector control activities. These
interventions are aimed to reduce the incidence of
malaria by at least 75 percent and to nearly eliminate
the number of malaria-related deaths by 2015 [11]. The
scaling-up of these interventions has already led to a
decline in the malaria burden in areas where the disease
is endemic [1,12].
Consequently, the World Health Organization (WHO)
recommends prompt and appropriate management of all
malaria cases with efficacious medicines [1]. Most SSA
countries have started to use arteminisinin combination
therapy (ACT), which is efficacious in the management
of uncomplicated malaria cases. In Tanzania, a fixed-
dose combination of artemether-lumefantrine (ALu) has
been used since 2006 for treating such uncomplicated
malaria cases. The use of ACT replaced sulphadoxine/
pyrimethamine (SP) that was hitherto used for treating
uncomplicated malaria cases on children above two
months of age and or weighing above 5 kgs and all
adults except in last trimester pregnancy cases, and lac-
tating mothers whose babies are below two months of
age [13,14]. To enhance access to ACT, ALu is also
made available at subsidized prices in the private retail
sector, which is dominated by accredited drug dispensing
outlets (ADDO) in Tanzania. The ADDO initiative is
aimed at improving the quality of care in the privatedrug retail sector [15]. Other anti-malarial drugs,
particularly monotherapy, are also readily available in
these outlets.
People in different communities may have different
opinions about illnesses, which inform their schemas
and perceptions of the efficacy of various medical options.
Indeed, cultural norms and beliefs tend to shape
treatment-seeking practices [16-18], including percep-
tions about susceptibility to malaria, the consequences
of the disease and the effectiveness of various malaria
treatments [19-21]. Self-medication for malaria using
retail drugs has been found to be common [22], in SSA
in general [23-27] and Tanzania in particular [28-31].
Thus, in this paper, the focus is to understand the malaria
self-care practices and motives for the choice of drug store
services.
Self-care as a concept
The concept of self-care in public health can be traced
back to the 1960s [32]. It has been defined as a process
in which individuals undertake disease prevention,
detection and treatment on their own without consult-
ation to healthcare providers; it entails self-diagnosis
and use of remedies previously prescribed for similar
illness and/or the purchase of medications without
professional advice [32-38]. Segall and Goldstein de-
scribe self-care as comprising potential behavioural
practices such as health maintenance, disease prevention,
assessment of symptoms, self-diagnosis, self-treatment
(non-medication treatments and self-medication), self-
referral, consultation with non-medical (alternative)
care practitioners, and the use of specialized medical
care [34]. WHO acknowledges self-care as a key aspect
of public health, which plays a pivotal role in the health
care system [22], despite the attendant risks, including
those associated with incorrect diagnosis and use of
non-prescribed medicines [39].
In public health research, theories and models on
health-seeking behaviour help explain the underlying
motivations for often multifaceted and complex people’s
care-seeking decisions [40]. In particular, the health belief
model (HBM) is widely applied to explain health-seeking
behaviour. This model centres on four concepts: the
perceived susceptibility to a disease, the perceived sever-
ity of the disease, the perceived benefits of the treatment
actions, and the perceived barriers to adopting proposed
measures. The model posits that what triggers individuals’
decisions regarding health-seeking behaviour are gen-
eral health motivations, including internal cues (i.e.
symptoms), and external cues (i.e. interpersonal interac-
tions and media communications) [41]. Subsequently, the
concept of self-efficacy was added to the model to refer
to an individual’s perceived ability to adopt and perform
specific actions successfully. This individual-centred model
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employed by individuals in need of healthcare.
The HBM concepts are also pertinent to self-care deci-
sions. In this regard, an individual’s perceptions of his or
her susceptibility to malaria and the perceived severity
of the condition will inform his/her perceptions of the
threats associated with leaving the condition unattended
to. This study has combined the theoretical concepts
from Self-care and HBM, to argue that self-care prac-
tices are more likely to be informed by individuals’
knowledge of malaria and perceived susceptibility to the
condition. Moreover, individuals’ perceptions regarding
the severity of the disease and the perceived benefits
associated with different treatments options for restor-
ing health will inform their self-care therapy choices.
Self-care in Tanzania
Studies on health care-seeking behaviour in response to
malaria among Tanzanians [42-46] shows that adults
reportedly turn to professional healthcare only when
the symptoms persist or worsen [43,44,46]. Research
suggests, however, that the medicines bought in drug
stores are often of poor quality, and are not used ra-
tionally in many developing countries [47], including
Tanzania [28,48,49]. Concerns that most malaria self-
treatment practices are inadequate, inappropriate and
ineffective have been expressed in relation to Tanzania
[29,30] and elsewhere [25,50,51]. In fact, self-care
increases the chances of using unnecessary medicines
while delaying seeking of appropriate treatment of the
illness, which may exacerbate and complicate the
disease. In this regard, the role of self-care in the devel-
opment of drug resistance, especially to anti-malarial
drugs, cannot be underestimated [23,24,50-53]. In this
paper, the specific attention is on why people choose
self-care practices in malaria treatment, and the mo-
tives for the choice of drug store services. Gaining such
an understanding of the motives behind malaria self-
care is critical in developing strategies for promoting
the use of appropriate medicines in the community.
This study was conducted as part of a larger project
that investigated health-seeking behaviour among adults
in the context of the epidemiological transition, with a
focus on malaria and diabetes. The results from other
parts of the project will be presented separately.
Methods
Study area and population
This study was conducted in Kilombero, one of the
six districts of the Morogoro region, located in the
southeastern part of Tanzania. Kilombero district has a
total area of 14,018 sq km and a population of 407,880
(202,789 men and 205,091 women) [54]. There are 54
health facilities in the district, including two hospitals(a designated district referral hospital and a hospital
owned by a private organization), four government
health centres and 48 dispensaries, some of which are
owned by the government, and some of which are
privately owned. The Kilombero district has long been
known for its malaria intensity [55,56], and although
the incidence of malaria has been reduced, the disease
is still the leading cause of morbidity and mortality in
the district [8]. The districts’ ecological and climatic
condition is suitable for both high and perennial
malaria transmission [57]. The malaria control pro-
grammes of the district have benefited for more than
50 years from the malaria research activities of the
Ifakara Health Institutes, as well as from the efforts of
several other malaria control stakeholders in the district.
Two villages were purposively selected for the study
with the help of district council health management
team members. The criteria for the section based on
their proximity to the designated district hospital. The
semi-urban village was located less than 5 km from
Ifakara town, while the distance between the rural
village and the town was 43 km. This discrepancy
provided the opportunity to capture semi-urban and
rural perspectives regarding self-care practices. The
total population of the two villages is 21,270: 12,823
people live in the semi-urban village and 8,447 people
live in the rural village. The majorities of the villagers
have no more than a primary school education, and are
small-scale farmers who grow mainly rice and maize.
The main sources of health services for the residents
of the semi-urban village are a laboratory facility and
four dispensaries, all of which are privately owned, and
which diagnose and treat malaria, along with other
health problems. There are also 14 drug shops located
in the village that sell a variety of medicines, including
anti-malarial drugs. The village has no government-
owned health facilities. As they live close to Ifakara,
the residents of this village can also access a number of
drug shops, laboratory facilities and dispensaries located
there. By contrast, the rural village has one private
laboratory facility that provides diagnostic services
only, and a government-owned village dispensary. This
dispensary provides both diagnostic tests and treat-
ments for malaria and other conditions. The inhabi-
tants of this village can obtain anti-malarial drugs from
the four drug shops located in their village or from
several other shops in the adjacent villages. They also
have the option of travelling to Ifakara to access treat-
ments or purchase medicines. There is no privately
owned health facility in this village.
Study design and participant recruitment
This is a qualitative, exploratory study in which the
views of adults were examined through focus group
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ducted between October 2012 and March 2013. The
purpose of the FGDs was to elicit a broad range of views
and opinions on malaria, malaria self-care practices and
motives for utilization of drug shop services. The goal of
the IDIs was to explore in greater depth individual
perceptions and experiences with malaria, and the
decision-making processes involved in malaria self-care
practices. The age range of the participants was 25–81
years. Of the 74 study participants (35 women and 39
men), 59 were involved in eight FGDs (with each made
up of seven to nine participants), and 15 participated in
the IDIs. In order to capture a wide range of opinions
and ideas, and taking into account the gender dynamics
in the community, FGDs were held separately for men
and women. The number of discussions and interviews
was determined after data saturation had been reached.
The FGD participants were purposively selected among
the adult residents of the community. The FGDs partic-
ipants’ inclusion criteria considered gender, being an
adult and a permanent residency in the study villages.
IDIs were conducted with adult individuals who had
direct experience with malaria 14 days prior to the date
of the interview. These individuals were purposively
selected from the community with the help of the village
leaders and none of them were involved in the FGDs. In
determining eligibility for participation in the study,
the research team visited individuals in their villages,
asking them about their fever history over the previous
two weeks, and using screening questions to determine
the individuals’ beliefs about the causes of the fever.
After it was established that malaria was the cause of
an individual’s fever, and that the individual met the
study’s inclusion criteria, the person was given detailed
information about the study, and was asked whether
he/she was willing to take part. If the individual
expressed an interest in and a willingness to partici-
pate, appointments for discussion were made based on
his/her availability. Most of the discussions took place
two days after the appointments at the participant’s
household.
Data collection
Two research assistants with a social science background
at postgraduate level were trained to conduct the study.
Together with authors, these assistants piloted the data
collection guides. The results from the pilot helped the
team to refine the guides before they were used in the
main study. The data collection took place in two separ-
ate rounds. The first round involved FGDs. The results
from this round were used to sharpen the IDI topic
guides before they were used in the second round of
data collection, which consisted of the IDIs. All of the
FGDs and the IDIs were facilitated by the authors. Ineach of the FGDs, one of the assistants took notes. Both
FGDs and IDIs were conducted in Swahili, a language
which was spoken by a majority of the participants.
These discussions were recorded, and verbatim tran-
scriptions of the recordings were undertaken within
48 hours of the time they were conducted. The tran-
scripts were reviewed and cross-checked for quality by
the authors before they were imported to NVivo 9 (QSR
International Pty Ltd, Australia). All the transcripts were
analysed in their original language. The analysis process
took place at two levels. The first level entailed the
development of inductive and deductive codes. This was
followed by a second level, in which the codes were
categorized into themes and family codes based on the
principles of the grounded theory and the concepts of
the HBM. After the deductive (HBM) and the inductive
concepts were combined, the following themes emerged:
(i) knowledge and malaria awareness; (ii) malaria self-
care practices; (iii) self-diagnosis and use of pain killers
(iv) self-diagnosis and the prescription of anti-malarial
drugs (v) self-referral for a malaria test (vi) self-medication:
a preference for monotherapy; (vii) motives for using
drug shop services; and, (viii) self-medication with alter-
native medicines.
Ethical approval
The study was given ethical approval by the institu-
tional review boards of the Faculty of Spatial Sciences,
the University of Groningen in The Netherlands, the
Ifakara Health Institute (IHI) in Tanzania, and the
National Tanzanian Medical Research Coordinating
Committee of the National Institute for Medical Re-
search (NIMR). Study participants in both FGDs and
IDIs provided verbal consent. To ensure the anonymity
of the study participants, all identifiers were removed
from the data, and only the opinions of the participants
are presented.
Results
Knowledge and malaria awareness
Levels of knowledge and awareness of malaria shape
people’s perceptions regarding their susceptibility to the
disease, and are key factors in health care-seeking
practices. In this study, the majority of the participants
displayed a basic knowledge of malaria, including the
possible consequences of the disease and its link with
mosquitoes. In the FGDs, participants described mal-
aria as a major health problem in the community and
as a threat to the lives of the majority of people. In
general, the participants agreed that everyone in the
community was potentially susceptible to the condi-
tion, regardless of his or her age. The high levels of
knowledge and awareness of malaria observed in this
setting reflect the prevention efforts of the malaria
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organizations conduct intensive media campaigns on
malaria, which include road shows, posters and leaf-
lets. Recently, radio and television have been used for
malaria control education, albeit mainly in urban and
semi-urban areas. However, radio, and especially the
local radio station Radio Pambazuko Kilombero, is a
key source of malaria information in rural areas. The
following explanation of how media raises community
awareness of malaria and its link to mosquito was
offered in an IDI:
“Yeah, it is what we are told everyday mosquitoes are
the ones causing even in the radios, hospital there…
there are advertisements/posters on mosquitoes
causing malaria… every day you will hear mosquito is
a dangerous insect… it causes malaria… malaria is
dangerous present quickly in the hospital to get service
when you think you have malaria”. Ashura female,
53 yearsa, b.
In all of the discussions, malaria, or homa ya malaria,
was said to produce a wide range of symptoms, includ-
ing high fever, coldness, tiredness, headaches, yellow
vomit, dizziness, joint pain, loss of appetite, yellow urine,
and diarrhoea. These symptoms are in line with clinical
descriptions of the disease. However, the participants
observed that these symptoms are not always taken
seriously as signs of malaria due to their perceived
non-specificity. During the interviews, most of the
participants said they did not become convinced thatTable 1 In-depth interview participants’ self-care actions to th
Name Sex Age (years) First action taken
Self-medicate/use painkiller Use AM
Uzuri Female 26 Yes
Zed Male 26 Yes
John Male 37 Yes
Salome Female 66 Yes
Xemp Male 46 Yes
Easter Female 34 Yes
Gift Female 51 Yes
Kheri Female 60 Yes
Mchome Male 50 Yes
Barua Male 65 Yes
Ashura Female 53 Yes
Daima Male 65 Yes
Kapera Male 60 Yes
Mfuko Male 46 Yes
Cheupe Female 34 Yes
*AM: Anti-malarial medicine.the symptoms were suggestive of malaria until after they
had used a painkiller and found that the symptoms
persisted. Participants considered a malaria test to be im-
portant in confirming their self-diagnosis, due to similarity
of symptoms to typhoid and other diseases.
Malaria self-care practices
In this study, malaria care seeking is seen as a process
that entails different activities at different levels. The
participants expressed concerns about the cost of using
health care facilities, frequent shortages of medicines,
and the attitudes and practices of health care workers;
noting that factors such as these affect their health-
seeking behaviour and discourage them from using the
services of health care facilities. In outlining their
perceived malaria symptoms, the participants reported
several self-care strategies (see Table 1) based on their
evaluation of the severity of their symptoms. They also
considered their perceptions regarding their ability to
use self-care strategies successful, and their perceptions
of the benefits of employing such strategies. A close
analysis of the data revealed that the care-seeking behav-
iours of the participants were similar in both the semi-
urban village and the rural village, and among men and
women. There were no apparent gender differences in
the self-care practices, though affordability was more of
a concern among women than men. In elaborating on
the malaria self-care practices identified in this study,
the following sections are structured according to the
theoretical concept of Segall and Goldstein [34] ex-
plained earlier in the paper.eir recent malaria episode
Second action taken
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A majority of study participants reported engaging in
self-diagnosis and self-medication of fever and pain
using painkillers, such as Panadol® (paracetamol) (see
Table 1). Participants perceived that the symptoms
resulted from normal tiredness due to hard work or
working in the sun, and that the painkiller would help.
The perceived benefits of the painkiller in reducing
fever and alleviating pains were also cited as motives
for self-medication. Most of the painkillers used were
either leftovers of medication used to treat previous
illnesses, or they were bought from general shops. The
participants explained that when the painkiller did not
provide them with relief from their symptoms, they
then started to consider further options.
“… after using that Panadol I did not get big changes,
I was getting little relief and after sometimes that
condition relapses into more severe form that is why I
thought it can be malaria and true when I went for a
to test I found it is malaria then I used medicines”.
Salome, female, 66 years.
The study participants reported waiting two to three
days after they first experienced the symptoms before
taking further action. The decision to wait was based on
the expectation that the symptoms would subside after
the use of the painkiller. It was not until participants
perceived their symptoms as more severe, which also
increased their perception of susceptibility to malaria,
that they reported taking further action.
“It took like two to three days … because I was thinking
it is just a normal tiredness due to work but after
observing I have used Panadol with no success it is when
I thought I better go for testing so that I know for sure
what exactly is the problem”. Xemp, male, 46 years.
The general use of painkillers observed in the study
may have been shaped by an individual’s long history of
treating febrile conditions, and his or her perceptions of
the benefits of painkillers in alleviating fever and pain.
The long-term impact of such practices on the health of
a user is of concern, but addressing this issue was not
possible in the current study.
Self-diagnosis and the prescription of anti-malarial drugs
A majority of the participants had been residents of the
study communities for many years. As malaria has been
endemic in the region, the people have learned to live
with it by developing cultural schemas for self-care. This
could be seen in the IDIs, in which some participants
reported self-medicating with anti-malarial drugs as
soon as they had symptoms, based on their strongperception that malaria was the cause. Participants
described their decision-making process regarding the
use of anti-malarials as follows:
“When I had that fever I knew completely it is malaria
due to how I was feeling … that cold, headache and
joint pains all these were severely paining, I knew it
will only be malaria and nothing else… so I decided to
use anti malaria and I am doing well”. Salome,
female, 66 years.
Individuals’ previous experiences in managing similar
conditions seem to have informed their self-medication
decisions. There appears to be a large reservoir of med-
ical knowledge in the community on malaria and its
treatments. This might be due to the social marketing
interventions in the area, coupled with individuals’ mul-
tiple exposure to bouts of the disease and to its treat-
ments. Thus, self-diagnosis and self-prescription were
often reported by the study participants:
“… so after feeling that condition… I thought it is
better I buy that amodiaquine because it is a medicine
that I am used to and whenever I have a malaria
condition like now ..when I just use it my condition
becomes better. I could have bought other medicines
but there was no need because my medicine which I
am used to was available”. Mchome, male, 50 years.
Self-referral for a malaria test
The perceived severity of symptoms and the increased
susceptibility to malaria triggered the need for a test.
Majority of IDI participants indicated they obtained mal-
aria tests from private laboratory diagnostic facilities.
Only a few of the interviewees went to a health care
facility for a laboratory test after painkillers failed to
relieve their pain. These private laboratory facilities are
found within the catchment area of the study commu-
nities, and are managed by trained laboratory practi-
tioners equipped to diagnosis conditions such as malaria
using a blood sample, and examination of other illnesses
using urine and stool samples. At the time of this study,
most of these facilities were using microscopic diagnos-
tic tests for malaria that cost 0.64$ (Tshs 1,000). The
interviewees reported referring themselves to these
facilities to confirm their self-diagnosis before deciding
on which medicine to use.
The perceptions that some malaria symptoms resem-
ble those associated with a urinary tract infection (UTI)
or typhoid were among the reasons cited for choosing to
take a malaria test. The participants observed that self-
diagnosis could lead to the wrong choice of medications,
leaving the true cause of the condition untreated, and
thus prolonging the duration of the illness:
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may hear someone has taken malaria medicines even
for three times but the fever do not stop… when they
go for checking [testing] they find the person has
typhoid while he was treating malaria… that is why
he was not getting cured so a situation like that does
exist and that is why it is important to test first before
taking any medicines to be sure which medicines you
use for what disease…” Gift, female, 51 years.
The high levels of awareness of malaria and of testing
options found in this study can be attributable to the
behaviour change and communication (BCC) activities
regarding prompt and effective malaria treatments that
have been undertaken in the district. Some of the
participants made reference to the instructions and
information people receive from different media chan-
nels on malaria treatment. The following statements
describe in detail some of the cues and motives for
taking a malaria test:
“Because information is already going around… people
are being instructed…. the media as well… is saying
‘…people you should not just start taking medications
before testing to know what disease is disturbing
because sometimes you may be suffering believing it is
malaria while it is not….it is just another disease …
now when you use anti-malaria medicines you cannot
get cured as a result you just hurt yourself ’... so we
listen to them that is why we test first for malaria
before using anti malaria medicines… we want to
know if it is malaria, how many parasites are there
and if it is not malaria what is the problem that
disturbing…” Daima, male, 65 years.
Self-medication: a preference for monotherapy
Despite the changes in malaria treatment guidelines in
Tanzania that recommend the use of combination ther-
apy, other anti-malarial treatment, many monotherapy,
are widely accessible through the private sector. The
results of this study show that a variety of anti-malarial
medicines were used in managing participants’ recent
malaria episodes. The use of monotherapy was reported
by the majority, leaving less than half of the participants
using the combination treatment/ALu that is recom-
mended as the first-line anti-malarial in Tanzania. How-
ever, a number of participants reported using a variety
of monotherapies in managing their recent bouts of
illness, including Metakelfin®, Fansidar®, Malafin®, Orodar®
and amodiaquine. These medicines were obtained from
drug shops. Most of the interview participants reported
choosing anti-malarial brands after the drug shop clerk
or service provider asked them: “What anti-malarial
medicine do you normally use?”.The perceived benefits and effectiveness associated
with specific medicines prompted their choice. The indi-
viduals’ previous experience with using the same medi-
cation to manage similar conditions may have motivated
their decision:
“…that one.... I just decided myself to use Orodar
because that is the medicine I normally use when I get
malaria… if I use that Orodar it does not disturb me I
just become well and continue with my normal
activities”. Ashura, female, 53 years.
A number of participants reasoned the length of the
treatments and the need to take multiple tablets as some
of the barriers for using ALu therapy. In elaborating on
this, participants gave examples in which they compared
the ease of using some monotherapy, especially single-
dose, with using ALu, which must be taken over three
days:
“…the problem with Mseto/ALu is those tablets … they
have made so many tablets …when the patient sees
them …he gets scared ….because I don’t know they are
like how many…. 24 tablets something like that… and
you are supposed to take all of them… that also I
think is not good… because when one is sick first of all
you just don’t like medicines.... now when the dosage
has many tablets it particularly disappoints you… I
think it is better they reduce the number of tablets a
bit… it will easy its use (will you use it?) no honestly I
like the one to use only once, these one [ALu] I think…
I will fail completely… I will just ask the doctor to
prescribe me another one to use once… isn’t it that
there are just various malaria medicines….” Uzuri,
female, 26 years.
However, the quality of medicines purchased in drug
shops, and specifically the monotherapy may be ques-
tionable, and their use may prevent malaria sufferers
from using more effective combination treatments.
Motives for using drug-shop services
Drug shops play a major role in managing malaria illness
in the community. In this study, all of the participants ex-
cept one said they had obtained their anti-malarial medi-
cines from drug shops, regardless of where the diagnosis
was made. These shops are widespread and easily access-
ible in the study villages. The privately owned shops offer
various types of anti-malarial drugs, usually with or with-
out a prescription. The majority of the clerks in these
shops are government trainees certified to sell a set of
essential drugs, including the combination treatment/ALu.
When asked why they chose to use drug shops, many
participants cited the cost of going to health care
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that when they think of visiting health care facilities,
many negative associations came to mind. For example,
one participant said a person would have to ask himself/
herself: “Do I have enough money to get treatments
there?” before visiting such a facility. This concern was
explained in detail in the interviews, in which partici-
pants reported not seeking care from the health facilities
because of limited funds:
“…due to the financial position one has, one may have
500 shillings only at hand, when you go there at the
health facility you are asked 1,000 shillings for
registration right… you are not yet given medication…
you are told to go and buy from the drug shop… now
it is better I take a short cut to buy medicines from the
drug shop and use… it is not that we fail to go for
testing there … it is a result of the financial ability….”
Barua, male, 65 years.
Participants reported taking such shortcuts to obtain-
ing medical services through providers such as drug
shops, because they knew visiting health care facilities
would entail more expense, i.e. for consultation, testing
and medicines, which they believed they could not
afford:
“ ….as a result of the amount of money I had… I
thought if I go there at the dispensary it won’t be
enough to buy medicines because I have to pay for
consultation first… that is why I decided taking short
cut to buy medications straight away and use”. Easter,
female, 34 years.
Members of the discussion groups complained that in
most cases the health care facilities do not have malaria
medicines on the premises, and that when they visit
such a facility they have to pay for consultations with
a practitioner who provides them with a paper prescrip-
tion, which they then have to take to the shop to be
filled. Participants voiced their concerns that drug
shortages, coupled with the procedures patients have to
follow at the health care facilities, forces patients to
perform the double role of both patient and doctor.
Thus, the study participants reported that taking re-
sponsibility for one’s own diagnosis, prescription, out-
come evaluation, and re-diagnosis is the norm. Health
care facilities are seen as a last resort when self-care
options have failed.
“…to a big percentage… we have become doctors for
ourselves because we are tired of going to the health
facilities. When one feels headache, leg pain, high
fever… you will hear saying go and buy me Mseto/Alu… he buys it and use, if he still feels fever he goes
to buy tablets for … for Amoeba believing that may be
this is Amoeba, when he uses it and find still not yet
…will go to maybe to his/her neighbour …the
neighbour will tell him perhaps it is urinary truck
infection [UTI] so he will go to the drug shop, buy
medicines and use. Now after seeing he/she have used
all these medicines and the condition is still persisting
… it is when another person will come and tell him
maybe it is typhoid, so now with typhoid he/she will go
for testing… currently people are tired of going to the
health facilities… we have become doctors ourselves
because drug shops are many and sometimes when
you go to the drug shop they advise … use this
medicine … so you feel it is better I go to the shop
rather than wasting all my time going to the health
facility, pay for consultation and waste the a full day
there at the end being told to go to buy medicines from
the shop…isn’t it better going to the shop directly?”
Female FGD1, 25 – 51 years, semi-urban village.
The participants also reported that the attitude toward
patients of the typical health care provider was among
their motivations for seeking care from the shops. They
said they believed they were not getting enough atten-
tion during health facility consultations, or that they had
to wait to receive services:
“Others [doctors] when you get there he just asks you
one question…‘what is the problem’…now as you
continue explaining your problem just at the middle of
the explanation he gives you a book [a prescription]
saying ‘go and buy these medicines…’ you see…now
this medicine I am going to buy is for what? I haven’t
yet explained my problem well for him to hear now he
has the prescription already … then when a person
sees that… would he really go to the health facility
again? You will go to the health facility to do what?
Then it is when you think you better go to the drug
shop and explain to that seller s/he would advise”.
Female FGD4, 25 – 46 years, rural village.
Self-medication with alternative medicines
Self-medication using alternative medicines was men-
tioned in both the FGDs and in IDIs as representing a
common practice in the study communities, although
none of the participants indicated that they had used
such medicines in managing their recent malaria epi-
sodes. Alternative medicines, such as neem tree roots
and leaves (mwarobaini), were frequently mentioned as
being used for treating malaria in the community.
Among the alternative medications mentioned were aloe
vera and mlonge (Moringe oliferus) leaves. It is widely
believed that the use of local herbs can significantly
Metta et al. Malaria Journal 2014, 13:249 Page 9 of 13
http://www.malariajournal.com/content/13/1/249delay the recurrence of malaria. The participants cited
the perceived benefits and efficacy of the herbs as motiv-
ation for their use as self-medication by the majority of
people in the community:
“… it is just many [people] who use local herbs and if
you use the tree [Neem tree] you stay for a very long
time … can be even six months before getting malaria
fever again… that is real a medicine as what the
elders just said … that tree is very helpful …” Male
FGD2, 43 – 80 years, semi-urban village.
The perceived benefits related to availability and self-
efficacy of local herbs was also cited as reasons why they
are used instead of western medicines. In many cases,
local herbs can be accessed at zero cost, as people can just
pick leaves or roots from the specific trees available in the
vicinity. The perceived benefits that local herb do not have
side-effects was cited as another motive for their use. In
addition, participants noted that many people doubt the
efficacy of the recommended treatments for malaria, and
thus prefer to use local herbs. The presence of various
anti-malarial drug brands on the market and the changes
in anti-malarial treatment policies were cited as signs of
the government’s uncertainty regarding the effectiveness
of anti-malarial medicines, and were thus seen as cues for
favouring the use of local herbs:
“I think there are two things… first treatment costs …if
you don’t have money what will you go for at the
health facility?… you will not get any help… secondly
the government is not sure of what is doing… as it is
making changes on malaria treatment medicines from
time to time… this becomes like they are not yet
certain on what medicine to use … instead they are
deciding to do research on us… so who wants to be
researched on? That is why people do not go there [the
health facility]… they don’t like those medicines they
believe it is better to use local medicines because
first of all…. these local medicines do not have side
effects ….” Mfuko, male, 46 years.
Two of the interview participants reported that they
often self-medicate using herbal remedies when they feel
unwell, even though they did not do so in the most
recent episode. A number of participants expressed the
belief that herbal medicines are preferable to conven-
tional medicines when a disease is still in its early stages.
They stated that alternative medicines act more slowly
on the human body than western medicines, and are
thus more effective in managing mild conditions:
“....what caused me not to use local herbs …is that
local herbs treat slowly… I mean… One should notwait until a person becomes completely serious then
you start giving him/her local herbs… that is not right
because at that stage you cannot give the medication
since local herb treatments delays but these medicines
of our colleagues… western medicines …treats quicker.
For instance if a person is dehydrated you cannot be
saying bring him local herbs and start administering….
you will welcome death. So my condition was a bit
worrying and had not yet prepared the medications …
I thought I use first these western medicines then I see
how it goes”. Xemp, male, 46 years.
Several participants also said that alternative medicines
could be useful in preventing diseases in some instances.
The Swahili term mwarobaini translates as ‘of forties’.
This ‘forties’ concept is reflected in the widely held
perception that mwarobaini can treat more than 40
diseases. As a consequence, many community mem-
bers believe that when this medicine is used, other
health problems that may be present in the body will
also be eliminated:
“…for us who use this mwarobain we know that it
treats many diseases… so you can use it ….if there is
another health problem in the body then it clears as
well. Sometimes you may find maybe rashes coming
out from the body ….so when you have rashes in the
body …there is another tree that you can use….and
that mwarobain you can as well take, boil and bath
with…all the rashes will disappear”. Kapera, male,
60 years.
Despite their use in managing malaria in the commu-
nity, the long-term impact of alternative medications
on the health of the users is not clear, and might need
further exploration.
Discussion
Successful malaria treatment depends largely on early
recognition of the disease symptoms and the subsequent
treatment through the use of effective anti-malarial
medicines. The current study reveals that care seeking
is a complex process characterized by multiple layers of
actions. The perceived susceptibility to the disease and
the meaning people attach to their symptom experiences
underlie many of the actions taken. Self-medication with
painkillers leftover from the treatment of previous illnesses
or bought from drug shops as an initial response to illness
was found to be common. Perceptions regarding the
mildness of the symptoms and the perceived benefits of
using a painkiller to relieve the condition motivated the
decision to self-medicate. Individuals decided whether
to seek additional help after observing the progress of
the illness, and their decisions were motivated by their
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susceptibility to the disease. The higher awareness on
malaria seen in the study could be a possible explan-
ation for the observed consistency in self-care practices
among men and women. The current study focused on
malaria self-care practices among adults. The results are
comparable to those of the studies conducted in other
parts of Tanzania [46,49] and other malaria endemic
regions [25,58,59] where self-medication was the first
response employed to malaria. This practice is unsafe as
it may delay effective treatment and prolong the suf-
ferer’s illness. The failure to seek prompt and effective
treatment within 24 hours of the onset of malaria symp-
toms can prevent communities from reaching malaria
control goals set by the government and global malaria
control organizations.
The correct diagnosis of malaria is indispensable in
ensuring that malaria sufferers are treated appropriately.
The government, in line with WHO’s recommendations
[60], advises people who suspect they have malaria to
take a malaria test before receiving treatment, in the
form of either microscopy or a rapid diagnostic test. The
results of this study showed, however, that the majority
of people wait to take anti-malarial drugs until after they
have taken a malaria test to confirm their self-diagnosed
condition. The failure of the initial self-medication prac-
tices to produce relief, the perceived severity of the
symptoms and the perceived degree of susceptibility to
the condition motivated the study participants to take a
malaria test. A preference for testing before taking anti-
malarial drugs has also been reported in other settings
[18,42]. Although a malaria test before the use of anti-
malarial drugs is recommended [60], the quality of the
malaria test services offered, especially in the private
sector, is questionable, and the use of such tests can lead
to the over-diagnosis of malaria [61]. The over-diagnosis
of malaria has considerable implications for malaria con-
trol, as it triggers the unnecessary use of anti-malarial
drugs, which can increase the chances of developing
drug resistance [62], and can exacerbate the suffering
that comes from untreated illnesses. In light of the
preference for a malaria test expressed in the study,
and of the need to safeguard the efficacy of anti-
malarial medicines, as the recent WHO’s T3: Test Treat
Track initiative for scaling up diagnostic tests indi-
cated, it may prove necessary to implement quality con-
trols and follow-up surveillance of malaria treatments.
Despite the shift to ACT in the country’s malaria treat-
ment policy, self-medication with monotherapy was found
to be common among study participants. The participants
expressed a preference for sulphadoxine-pyrimethamine,
sulphamethoxypyrazine-pyrimethamine and amodiaquine
medicines over the recommended combination treatments/
ALu. Individual participants’ experiences in managing asimilar condition and their perceptions of the benefits
and effectiveness of specific brands strengthened their
confidence in their self-treatment choice. These per-
ceptions were often reinforced by the ease of using
monotherapy, which are administered as single doses.
The continued use of monotherapy, despite the recom-
mendation that combination treatments be used, has also
been reported in Ghana, where chloroquine, artemether,
amodiaquine, quinine, and sulphadoxine-pyrimethamine
are used by the majority of malaria sufferers [59]. The
ongoing use of these brands for malaria management
might seriously impair malaria control efforts, as anti-
malarial monotherapy is known to cause resistance to
malaria parasites [27,62-64]. Thus, their use may contrib-
ute to the increased resistance of malaria parasites to
effective anti-malarial medicines.
Recent reviews [23,27] have shown that drug shops
are the main source of malaria medicines used for self-
treatment. The same observation was made in the
current study. The cost of medication and services,
shortages of medicines, waiting times for receiving
services, and the attitudes toward patients displayed by
health care workers were cited by participants as
motives for accessing drug shops directly. These find-
ings are comparable to results previously reported for
the research district [56,65] and for other settings [66].
Although many people obtain medicines from shops
when self-medicating for malaria [28,30,31,49,56,67],
the quality of those medicines is worrying [48,68,69].
The use of ineffective treatments can lead to avoidable
morbidities and deaths, and to the continuing spread
of disease parasites in the community. To improve the
quality of the medications dispensed in drug shops, the
ADDO programme was implemented in Tanzania in
2006 [15]. The continuous monitoring of the quality of
the medicines sold in drug shops, and of dispensing
behaviour in these shops, would be beneficial. The
availability and accessibility of more effective anti-
malarial drugs, such as ACT, in drug shops need to be
assessed. In addition, community members should be
informed of the potential benefits of ACT, and encour-
aged to use them.
The use of local herbs in self-treatment of malaria was
reported as a normal practice in this study. The partici-
pants indicated that they perceive local herbs, or mwaro-
baini, as having no negative effects on the user and as
being effective in curing multiple conditions. Although the
use of local herbs for malaria management is not new in
Tanzania [19,21,70,71] or in other parts of SSA [72-74],
the motives for the practice appear to be changing. Previ-
ous studies have found that many people O;JKLassociate
severe malaria with degedege, which may lead them to
choose traditional/local medicines [16,18,19,21,70,75].
The results of this study indicated that local herbs are
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A lack of faith or uncertainty regarding the effectiveness
of the recommended combination treatments/ALu was
among the reasons cited by participants for the use of
local herbs. The availability of various anti-malarial
drug brands in the market, coupled with frequent policy
changes regarding treatments, has led many members of
the community to question the efficacy of the recom-
mended treatments. However, it is not clear whether the
use of local herbs can lead to a concentration of toxins
that could be harmful to the human body. Currently, little
is known about the ability of local mwarobaini herbs to
treat malaria, or about their safety in humans.
This study was conducted in a district with a long
history of malaria disease, including communities that
have been intensively involved in several malaria con-
trol and management interventions [68,76]. The finding
that self-care is practiced widely in this particular
setting suggests it is also practiced elsewhere. However,
as the study was conducted using a small group of people
in a specific setting, the results should be viewed as
contextual, and any generalization of the findings should
be limited to this kind of setting. Nevertheless, the study’s
results provide valuable insights into the motives for
malaria self-care among adults in the community. This
is important, as it can help to inform policy decisions
regarding the planning and implementation of pro-
grammes aimed at improving the effective and appro-
priate management of malaria.
Conclusion
This study has shown that malaria self-care among
adults is motivated by people’s perceptions and schemas
on the disease and the health care options available to
them. The actions taken by the study participants reflect
the economic inequalities that exist in the community.
Though there have been sustained malaria interventions
in the region the access to appropriate treatment has
been limited. There is a need for public health interven-
tions to take into account community perceptions and
cultural schemas on malaria self-care practices.
Endnotes
aAll quotes have been translated from Swahili to
English hence they may not follow strict grammatical rules.
bAll names used are fictitious, and do not reveal the
true identity of the study participants.
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